Switching from Farxiga to Xigduo
Yes, you can switch from Farxiga (dapagliflozin) to Xigduo (dapagliflozin/metformin fixed-dose combination), and this is a straightforward transition that simply adds metformin to your existing dapagliflozin therapy. 1, 2
Understanding the Medication Switch
Xigduo is essentially Farxiga plus metformin in a single tablet. 2 Farxiga contains only dapagliflozin, while Xigduo combines dapagliflozin with metformin extended-release in fixed doses. 1, 3 This switch represents intensification of diabetes therapy by adding metformin to your SGLT2 inhibitor regimen. 4, 5
Clinical Rationale for This Switch
Metformin is the preferred foundational therapy for type 2 diabetes and should be initiated at diagnosis unless contraindicated. 4, 6, 5, 7, 5
Combination therapy with dapagliflozin and metformin provides complementary mechanisms of action: dapagliflozin increases urinary glucose excretion while metformin reduces hepatic glucose production and improves insulin sensitivity. 8, 3
The fixed-dose combination can improve medication adherence compared to taking multiple separate pills, which may enhance glycemic control. 3
Clinical trials demonstrate that dapagliflozin plus metformin reduces HbA1c by up to 2%, produces weight loss of 2-3 kg, and modestly lowers systolic blood pressure by 3-5 mmHg. 3
How to Make the Switch
Simply stop Farxiga and start Xigduo at the appropriate dose based on your current dapagliflozin dose and renal function. 9, 1
Dosing Algorithm:
If you are taking Farxiga 10 mg daily and have eGFR ≥45 mL/min/1.73 m²: Start Xigduo XR 10 mg/1000 mg once daily with the evening meal. 1, 3
If you are taking Farxiga 5 mg daily and have eGFR ≥45 mL/min/1.73 m²: Start Xigduo XR 5 mg/1000 mg once daily with the evening meal. 1
If your eGFR is 30-44 mL/min/1.73 m²: Metformin dose should be limited to maximum 1000 mg/day, so use lower-dose Xigduo formulations. 9
If your eGFR is <30 mL/min/1.73 m²: Do not use Xigduo, as metformin is contraindicated at this level of renal function. 5, 9
Critical Pre-Switch Assessment
Check your renal function (eGFR) before making this switch. 9 Metformin has specific renal dosing requirements and is contraindicated when eGFR <30 mL/min/1.73 m². 5, 9
Renal Function Checklist:
eGFR ≥60 mL/min/1.73 m²: No metformin dose adjustment needed; proceed with standard Xigduo dosing. 9
eGFR 45-59 mL/min/1.73 m²: Consider reducing metformin to half the maximum dose; monitor renal function every 3-6 months. 9
eGFR 30-44 mL/min/1.73 m²: Limit metformin to maximum 1000 mg/day; monitor renal function every 3 months. 9
eGFR <30 mL/min/1.73 m²: Metformin is contraindicated; do not use Xigduo. 5, 9
Important Safety Considerations
The combination of dapagliflozin and metformin has low hypoglycemia risk when used without sulfonylureas or insulin, so no preemptive dose reductions of other medications are typically needed. 9
Metformin may cause gastrointestinal side effects (bloating, abdominal discomfort, diarrhea) in up to 30% of patients; these can be mitigated by gradual dose titration and taking the medication with food. 5, 3
Continue the same sick-day management rules for dapagliflozin: Hold Xigduo during acute illness with reduced oral intake, fever, vomiting, or diarrhea to prevent volume depletion and ketoacidosis. 9
Withhold Xigduo at least 3 days before major surgery or procedures requiring prolonged fasting to prevent postoperative ketoacidosis. 9
Monitor for genital mycotic infections (approximately 6% incidence with SGLT2 inhibitors); maintain good genital hygiene to reduce risk. 9
Long-term metformin use is associated with vitamin B12 deficiency; periodic measurement of B12 levels should be considered, especially if anemia or peripheral neuropathy develops. 6, 5, 7
Monitoring After the Switch
Recheck eGFR within 1-2 weeks after starting Xigduo, as both dapagliflozin and metformin can affect renal function. 9
Monitor HbA1c every 3 months to assess glycemic response to the combination therapy. 4, 5
If eGFR ≥60 mL/min/1.73 m²: Recheck renal function annually. 9
If eGFR 45-59 mL/min/1.73 m²: Recheck renal function every 3-6 months. 9
When NOT to Make This Switch
Do not switch to Xigduo if:
History of lactic acidosis (metformin contraindicated). 10
Severe hepatic impairment (metformin contraindicated). 5
Acute or chronic metabolic acidosis (metformin contraindicated). 5
Current acute illness with risk of tissue hypoxia (hold metformin temporarily). 5
Cardiovascular and Renal Benefits Are Preserved
The cardiovascular and renal protective effects of dapagliflozin are maintained when combined with metformin. 9, 11 Dapagliflozin reduces cardiovascular death or heart failure hospitalization by 29% and slows kidney disease progression regardless of whether it is used alone or with metformin. 9